Quantinno Capital Management LP Lowers Stake in Envista Holdings Co. (NYSE:NVST)

Quantinno Capital Management LP lessened its position in shares of Envista Holdings Co. (NYSE:NVST) by 38.4% in the 3rd quarter, HoldingsChannel reports. The fund owned 55,792 shares of the company’s stock after selling 34,803 shares during the period. Quantinno Capital Management LP’s holdings in Envista were worth $1,102,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. CWM LLC raised its position in shares of Envista by 203.3% in the 2nd quarter. CWM LLC now owns 14,899 shares of the company’s stock valued at $248,000 after purchasing an additional 9,986 shares during the last quarter. Raymond James & Associates boosted its holdings in Envista by 22.6% in the second quarter. Raymond James & Associates now owns 1,032,350 shares of the company’s stock valued at $17,168,000 after purchasing an additional 190,240 shares during the last quarter. Leeward Investments LLC MA raised its position in Envista by 1.1% during the second quarter. Leeward Investments LLC MA now owns 640,589 shares of the company’s stock valued at $10,653,000 after acquiring an additional 6,982 shares in the last quarter. Shayne & Jacobs LLC boosted its holdings in Envista by 12.0% during the second quarter. Shayne & Jacobs LLC now owns 62,600 shares of the company’s stock worth $1,041,000 after buying an additional 6,700 shares in the last quarter. Finally, Hedges Asset Management LLC purchased a new stake in shares of Envista during the 2nd quarter worth about $532,000.

Envista Stock Performance

Shares of NVST stock opened at $20.33 on Friday. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $25.64. The company has a market cap of $3.50 billion, a P/E ratio of -2.62, a PEG ratio of 2.77 and a beta of 1.31. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The firm has a fifty day moving average price of $20.06 and a 200 day moving average price of $18.42.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. The firm had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. During the same period last year, the firm posted $0.43 EPS. The company’s revenue was down 4.8% on a year-over-year basis. Sell-side analysts predict that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

NVST has been the subject of several recent analyst reports. Robert W. Baird boosted their price target on shares of Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Leerink Partnrs raised Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Evercore ISI increased their price target on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and boosted their price objective for the company from $16.00 to $23.00 in a report on Thursday, October 31st. Finally, Wells Fargo & Company assumed coverage on Envista in a research note on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 price target on the stock. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.65.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.